185 related articles for article (PubMed ID: 27206513)
1. Effectiveness of N-acetylcysteine for preserving residual renal function in patients undergoing maintenance hemodialysis: multicenter randomized clinical trial.
Ahmadi F; Abbaszadeh M; Razeghi E; Maziar S; Khoidaki SD; Najafi MT; Lessan-Pezeshki M
Clin Exp Nephrol; 2017 Apr; 21(2):342-349. PubMed ID: 27206513
[TBL] [Abstract][Full Text] [Related]
2. N-acetylcysteine may improve residual renal function in hemodialysis patients: a pilot study.
Feldman L; Shani M; Sinuani I; Beberashvili I; Weissgarten J
Hemodial Int; 2012 Oct; 16(4):512-6. PubMed ID: 22541137
[TBL] [Abstract][Full Text] [Related]
3. Three Versus 4 Daily Exchanges and Residual Kidney Function Decline in Incident CAPD Patients: A Randomized Controlled Trial.
Yan H; Fang W; Lin A; Cao L; Ni Z; Qian J
Am J Kidney Dis; 2017 Apr; 69(4):506-513. PubMed ID: 27751610
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin blockade and progressive loss of kidney function in hemodialysis patients: a randomized controlled trial.
Kjaergaard KD; Peters CD; Jespersen B; Tietze IN; Madsen JK; Pedersen BB; Novosel MK; Laursen KS; Bibby BM; Strandhave C; Jensen JD
Am J Kidney Dis; 2014 Dec; 64(6):892-901. PubMed ID: 25011693
[TBL] [Abstract][Full Text] [Related]
5. Effect of N-acetylcysteine pretreatment of deceased organ donors on renal allograft function: a randomized controlled trial.
Orban JC; Quintard H; Cassuto E; Jambou P; Samat-Long C; Ichai C
Transplantation; 2015 Apr; 99(4):746-53. PubMed ID: 25250647
[TBL] [Abstract][Full Text] [Related]
6. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study.
Li PK; Chow KM; Wong TY; Leung CB; Szeto CC
Ann Intern Med; 2003 Jul; 139(2):105-12. PubMed ID: 12859160
[TBL] [Abstract][Full Text] [Related]
7. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
Chong E; Poh KK; Lu Q; Zhang JJ; Tan N; Hou XM; Ong HY; Azan A; Chen SL; Chen JY; Ali RM; Fang WY; Lau TW; Tan HC
Int J Cardiol; 2015 Dec; 201():237-42. PubMed ID: 26301645
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine improves residual renal function in peritoneal dialysis patients: a pilot study.
Feldman L; Shani M; Efrati S; Beberashvili I; Yakov-Hai I; Abramov E; Sinuani I; Rosenberg R; Weissgarten J
Perit Dial Int; 2011; 31(5):545-50. PubMed ID: 20705950
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of mycophenolate mofetil on residual renal function in peritoneal dialysis patients: An open label feasibility study.
Wang X; Zhang X; Lu S; Liu D; Chen G; Dou Y; Yuan W; Ma S; Li Y; Xiao J; Zhao Z
Nephrology (Carlton); 2017 Dec; 22(12):954-960. PubMed ID: 27558768
[TBL] [Abstract][Full Text] [Related]
10. Effects of residual renal function on left ventricle and analysis of related factors in patients with hemodialysis.
Ma T; Ding G
Ren Fail; 2013; 35(2):198-203. PubMed ID: 23181804
[TBL] [Abstract][Full Text] [Related]
11. Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine.
Rashid ST; Salman M; Myint F; Baker DM; Agarwal S; Sweny P; Hamilton G
J Vasc Surg; 2004 Dec; 40(6):1136-41. PubMed ID: 15622367
[TBL] [Abstract][Full Text] [Related]
12. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients.
Wang AY; Wang M; Woo J; Law MC; Chow KM; Li PK; Lui SF; Sanderson JE
Kidney Int; 2002 Aug; 62(2):639-47. PubMed ID: 12110029
[TBL] [Abstract][Full Text] [Related]
13. Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine.
Feldman L; Efrati S; Eviatar E; Abramsohn R; Yarovoy I; Gersch E; Averbukh Z; Weissgarten J
Kidney Int; 2007 Aug; 72(3):359-63. PubMed ID: 17457375
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
Ataei S; Hadjibabaie M; Moslehi A; Taghizadeh-Ghehi M; Ashouri A; Amini E; Gholami K; Hayatshahi A; Vaezi M; Ghavamzadeh A
Hematol Oncol; 2015 Jun; 33(2):67-74. PubMed ID: 24711000
[TBL] [Abstract][Full Text] [Related]
15. Effect of N-acetylcysteine on serum creatinine and kidney function: results of a randomized controlled trial.
Moist L; Sontrop JM; Gallo K; Mainra R; Cutler M; Freeman D; House AA
Am J Kidney Dis; 2010 Oct; 56(4):643-50. PubMed ID: 20541301
[TBL] [Abstract][Full Text] [Related]
16. Does intravenous or oral high-dose N-acetylcysteine in addition to saline prevent contrast-induced nephropathy assessed by cystatin C?
Erturk M; Uslu N; Gorgulu S; Akbay E; Kurtulus G; Akturk IF; Akgul O; Surgit O; Uzun F; Gul M; Isiksacan N; Yildirim A
Coron Artery Dis; 2014 Mar; 25(2):111-7. PubMed ID: 24365793
[TBL] [Abstract][Full Text] [Related]
17. Independent effects of residual renal function and dialysis adequacy on nutritional status and patient outcome in continuous ambulatory peritoneal dialysis.
Szeto CC; Lai KN; Wong TY; Law MC; Leung CB; Yu AW; Li PK
Am J Kidney Dis; 1999 Dec; 34(6):1056-64. PubMed ID: 10585315
[TBL] [Abstract][Full Text] [Related]
18. Effect of Icodextrin Solution on the Preservation of Residual Renal Function in Peritoneal Dialysis Patients: A Randomized Controlled Study.
Chang TI; Ryu DR; Yoo TH; Kim HJ; Kang EW; Kim H; Chang JH; Kim DK; Moon SJ; Yoon SY; Han SH;
Medicine (Baltimore); 2016 Mar; 95(13):e2991. PubMed ID: 27043667
[TBL] [Abstract][Full Text] [Related]
19. Therapy of hyperhomocysteinemia in hemodialysis patients: effects of folates and N-acetylcysteine.
Perna AF; Violetti E; Lanza D; Sepe I; Bellinghieri G; Savica V; Santoro D; Satta E; Cirillo G; Lupo A; Abaterusso C; Raiola I; Raiola P; Coppola S; Di Iorio B; Tirino G; Cirillo M; Ingrosso D; De Santo NG
J Ren Nutr; 2012 Sep; 22(5):507-514.e1. PubMed ID: 22226754
[TBL] [Abstract][Full Text] [Related]
20. Acetylcysteine has No Mechanistic Effect in Patients at Risk of Contrast-Induced Nephropathy: A Failure of Academic Clinical Science.
Sandilands EA; Rees JMB; Raja K; Dhaun N; Morrison EE; Hickson K; Wraight J; Gray T; Briody L; Cameron S; Thompson AP; Johnston NR; Uren N; Goddard J; Treweeke A; Rushworth G; Webb DJ; Bateman DN; Norrie J; Megson IL; Eddleston M
Clin Pharmacol Ther; 2022 Jun; 111(6):1222-1238. PubMed ID: 35098531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
